<?xml version="1.0" encoding="UTF-8"?>
<p>A new live attenuated TB vaccine, named MTBVAC, has been found to induce not only specific T-cell immunity, but also long-term epigenetic and metabolic reprogramming of the cells of innate immune system through a process termed ‘trained immunity.’
 <sup>
  <xref rid="cit0069" ref-type="bibr">69</xref>
 </sup> The trained immunity has been found to confer protection against experimental lethal pneumonia infections.
 <sup>
  <xref rid="cit0070" ref-type="bibr">70</xref>
 </sup> The modified MTBVAC vaccine promotes proinflammatory genes, and facilitates an enhanced response after nonrelated bacterial stimuli.
</p>
